The effects of sitagliptin on lipid and glucose metabolism

The effects of sitagliptin on lipid and glucose metabolism - SL-Tokyo

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220036

Enrollment

200

Registered

2010-03-15

Start date

2010-03-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

Intervention type:DRUG Name of intervention:medication (sitagliptin) Dose form / Japanese Medical Device Nomenclature:TABLET Route of administration / Site of application:ORAL Dose per administration:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes

Exclusion criteria

Exclusion criteria: Those on insulin therapy, oral glucose-lowering medication, or lipid-lowering medication

Design outcomes

Primary

Measure	Time frame
lipoprotein profile (lipoprotein subfractions)	—

Countries

Japan

Contacts

Public ContactMasumi Ai

Tokyo Medical and Dental University

ai.bec@tmd.ac.jp+81-3-5803-4724

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026